We are engaged in a rapidly evolving field. We compete primarily with established pharmaceutical companies like Pfizer, Bristol-Myers Squibb and Schering-Plough, emerging biotechnology companies like Alza, Cygnus and Elan, as well as research and academic institutions, amongst others. Competition is intense and expected to increase.
Well that says it all (from the 10K). All the longs here who have stated and believed the technology was special, with no competition...well the company admits otherwise.